Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 12.35 -0.39 (3.06%)
Previous Close $12.74    52 Week High $30.40 
Open $12.50    52 Week Low $11.86 
Day High $12.82    P/E N/A 
Day Low $12.19    EPS $0.00 
Volume 3,637,267